TipRanks
Go Ultimate55% OFF

ArriVent BioPharma, Inc. (AVBP) Balance Sheet

ArriVent BioPharma, Inc. Balance Sheet

ArriVent BioPharma, Inc.'s total assets for Q2 2026 were $394.72M, an increase of 13.00% from the previous quarter. AVBP total liabilities were $27.88M for the fiscal quarter, a 10.12% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 333.17M$ 274.94M$ 163.10M$ 182.83M$ 43.04M
$ 25.95M$ 17.29M$ 11.80M$ 8.37M$ 1.82M
$ 307.22M$ 257.65M$ 151.30M$ 174.46M$ 41.22M

Currency in USD

ArriVent BioPharma, Inc. Debt to Assets

0120M240M360M4 %6 %8 %10 %LiabilitiesDebt to Assets20212022202320242025AssetsLiabilitiesDebt to Assets